Cronos CRON
NASDAQ CRON
$3.22 -0.07 (-1.98%)
At close: Aug 20, 2026 · 2:54 PM UTC

Cronos (CRON) Restructuring Costs (2023 - 2026)

Cronos (CRON) posted quarterly Restructuring Costs of $484000.0 for Q1 2026, down 12.79% year-over-year from $555000.0 in Q1 2025, and down 3.59% quarter-over-quarter from $502000.0 in Q4 2025.

Cronos (CRON) Restructuring Costs (2023 - 2026) Analysis & Trends

Cronos' Restructuring Costs history runs 4 years deep, the most recent figure standing at $484000.0 for Q1 2026.

  • In Q1 2026, Restructuring Costs fell 12.79% year-over-year to $484000.0; the TTM figure through Mar 2026 stood at $2.0 million (up 78.4% YoY), while the FY2025 annual figure was $2.0 million, up 223.33% from the prior year.
  • Restructuring Costs for Q1 2026 stood at $484000.0, down from $502000.0 in the prior quarter.
  • The five-year high for Restructuring Costs was $1.4 million in Q3 2023, with the low at $83000.0 in Q1 2024.
  • The 4-year median for Restructuring Costs is $502000.0 (2025), against an average of $519444.4.
  • The sharpest annual moves came in 2025 and 2026: Restructuring Costs soared 568.67% in 2025, then declined 12.79% in 2026.
  • Cronos' Restructuring Costs stood at $101000.0 in 2023, then jumped by 441.58% to $547000.0 in 2024, then dropped by 8.23% to $502000.0 in 2025, then declined by 3.59% to $484000.0 in 2026.
  • Business Quant data shows CRON's Restructuring Costs at $484000.0 in Q1 2026, $502000.0 in Q4 2025, and $212000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn
3 Zoetis 31.53 Bn 29.85 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn
5 United Therapeutics 22.13 Bn 19.47 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Cronos 1.20 Bn 407.87 Mn 28.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 308,000.00
Mar 31, 2026 484,000.00
Dec 31, 2025 502,000.00
Sep 30, 2025 212,000.00
Jun 30, 2025 768,000.00
Mar 31, 2025 555,000.00
Jun 30, 2024 547,000.00
Mar 31, 2024 83,000.00
Dec 31, 2023 101,000.00
Sep 30, 2023 1.42 Mn